NEA Management Company as of Dec. 31, 2018
Portfolio Holdings for NEA Management Company
NEA Management Company holds 46 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 30.7 | $774M | 10M | 74.25 | |
| Elastic N V ord (ESTC) | 18.0 | $454M | 6.4M | 71.48 | |
| Rhythm Pharmaceuticals (RYTM) | 5.2 | $132M | 4.9M | 26.88 | |
| Allakos (ALLK) | 4.7 | $119M | 2.3M | 52.27 | |
| Ra Pharmaceuticals | 4.4 | $112M | 6.1M | 18.20 | |
| Adaptimmune Therapeutics (ADAP) | 3.6 | $91M | 16M | 5.75 | |
| Glycomimetics (GLYC) | 3.4 | $86M | 9.1M | 9.47 | |
| Senseonics Hldgs (SENS) | 3.2 | $80M | 31M | 2.59 | |
| Crispr Therapeutics (CRSP) | 2.4 | $60M | 2.1M | 28.57 | |
| Obseva Sa | 2.3 | $58M | 4.6M | 12.66 | |
| Liquidia Technologies (LQDA) | 2.1 | $54M | 2.5M | 21.66 | |
| Epizyme | 1.7 | $42M | 6.9M | 6.16 | |
| AVEO Pharmaceuticals | 1.3 | $33M | 21M | 1.60 | |
| Mersana Therapeutics (MRSN) | 1.3 | $33M | 8.1M | 4.08 | |
| Aurinia Pharmaceuticals (AUPH) | 1.3 | $33M | 4.8M | 6.82 | |
| Clementia | 1.3 | $32M | 2.7M | 11.76 | |
| Synlogic | 1.2 | $30M | 4.2M | 7.01 | |
| Marker Therapeutics Ord | 1.1 | $28M | 5.0M | 5.55 | |
| Ardelyx (ARDX) | 1.1 | $27M | 15M | 1.79 | |
| Dermira | 1.0 | $25M | 3.5M | 7.19 | |
| Strongbridge Bioph shs usd | 0.7 | $19M | 4.1M | 4.48 | |
| Proteostasis Therapeutics In | 0.7 | $18M | 5.6M | 3.24 | |
| Affimed Therapeutics B V | 0.6 | $16M | 5.1M | 3.11 | |
| Lexicon Pharmaceuticals (LXRX) | 0.6 | $16M | 2.4M | 6.64 | |
| Mei Pharma | 0.6 | $15M | 5.7M | 2.64 | |
| Surface Oncology | 0.6 | $14M | 3.3M | 4.24 | |
| Millendo Therapeutics | 0.6 | $14M | 1.8M | 7.95 | |
| Dasan Zhone Solutions | 0.5 | $13M | 956k | 13.91 | |
| Bloom Energy Corp (BE) | 0.5 | $13M | 1.3M | 9.98 | |
| Champions Oncology (CSBR) | 0.5 | $12M | 1.6M | 7.81 | |
| Verona Pharma Plc ads (VRNA) | 0.4 | $11M | 1.2M | 9.00 | |
| Nightstar Therapeutics | 0.3 | $8.2M | 714k | 11.52 | |
| Rigel Pharmaceuticals | 0.3 | $7.5M | 3.2M | 2.30 | |
| Genocea Biosciences | 0.3 | $7.3M | 25M | 0.29 | |
| ArQule | 0.3 | $7.0M | 2.5M | 2.77 | |
| Achaogen | 0.2 | $6.4M | 5.2M | 1.23 | |
| Arsanis | 0.2 | $4.6M | 2.0M | 2.32 | |
| Erytech Pharma Sa | 0.2 | $4.2M | 625k | 6.77 | |
| Cti Biopharma | 0.1 | $2.7M | 3.8M | 0.73 | |
| Tracon Pharmaceuticals | 0.1 | $2.2M | 3.5M | 0.63 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $2.1M | 1.3M | 1.71 | |
| Endologix | 0.1 | $1.8M | 2.5M | 0.72 | |
| Trevena | 0.1 | $1.6M | 3.8M | 0.43 | |
| Akari Therapeutics | 0.0 | $710k | 452k | 1.57 | |
| Regulus Therapeutics | 0.0 | $852k | 916k | 0.93 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $545k | 1.3M | 0.42 |
